Results 161 to 170 of about 213,470 (338)

Pulmonary artery pressure trajectories in heart failure patients treated with GLP‐1 receptor agonists

ESC Heart Failure, EarlyView.
Abstract Aims Data support favourable haemodynamic benefits of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) on improving cardiac structural abnormalities and function in patients with heart failure (HF). However, the direct haemodynamic effects of GLP‐1 RAs remain inadequately characterized.
Haoran Jiang, Phuuwadith Wattanachayakul, Veraprapas Kittipibul, Erika Nicolsen, Todd McVeigh, Oksana Kamneva, Marat Fudim   +6 more
wiley   +1 more source

Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry

Journal of Lipid Research, 1999
Percent cholesterol absorption was measured in 94 normal subjects aged 17–80 years while consuming diets generally low in cholesterol (mean intake = 226 ± 126 mg/day).
Matthew S. Bosner, Louis G. Lange, William F. Stenson, Richard E. Ostlund, Jr.   +3 more
doaj  

PURIFICATION AND CRYSTALLIZATION OF GLUCAGON

, 1955
Alfred Staub, L. G. Sinn, Otto K. Behrens   +2 more
openalex   +1 more source

Multiomics insight into the role of glucagon‐like peptide‐1 receptor agonists in heart failure

ESC Heart Failure, EarlyView.
Graphical abstract of the multiomics insight into the role of GLP1Ra in cardiovascular diseases and the underlying pathway. GLP1Ra, glucagon‐like peptide‐1 receptor agonist. Abstract Aims Cardiovascular diseases, such as atrial fibrillation, coronary artery disease, heart failure (HF) and ischaemic stroke, are leading causes of death globally and exert
Yuhang Tao, Qi Liu, Yuxing Wang, Yingchao Gong, Mingying Xu, Ruhong Jiang, Kai Zhang   +6 more
wiley   +1 more source

Cardiac Actions of Glucagon [PDF]

, 1968
Benedict R. Lucchesi, Jeanne Brown, Barbara Laidlaw, Deonna Rockiki   +3 more
openalex   +1 more source

INTRAVENOUS GLUCAGON [PDF]

The Lancet, 1971
openaire   +3 more sources

Real‐world use of guideline‐directed therapy for heart failure: Insights from the Danish Heart Failure Registry

ESC Heart Failure, EarlyView.
Our study examined the real‐world implementation of guideline‐directed medical therapy (GDMT) and its association with mortality and hospitalization in 46 816 patients with heart failure with reduced ejection fraction (HFrEF) from the Danish Heart Failure Registry (2008–2022).
Inge Schjødt, Jan B. Valentin, Søren P. Johnsen, Rikke E. Mols, Kenneth Egstrup, Brian B. Løgstrup   +5 more
wiley   +1 more source

The Role of Glucose, Glucagon and Glucocorticoids in the Regulation of Liver Glycogen Synthesis [PDF]

, 1968
Henri De Wulf, H G Hers
openalex   +1 more source

Interconnected pathways and emerging therapies in chronic kidney disease and heart failure: A comprehensive review

ESC Heart Failure, EarlyView.
Abstract Chronic kidney disease (CKD) and chronic heart failure (HF) frequently coexist and, when comorbid, are associated with poorer outcomes. These two diseases have common risk factors, such as diabetes, obesity and hypertension, and common pathophysiological connected mechanisms, including inflammation, endothelial dysfunction, neurohormonal ...
Johann Bauersachs, Eri Toda Kato, Janani Rangaswami   +2 more
wiley   +1 more source

Hemodynamic Effects of Glucagon in Patients with Heart Disease [PDF]

, 1969
John F. Williams, RICHARD H. CHILDRESS, Jerold N. Chip, John F. Border   +3 more
openalex   +1 more source